Enolase-phosphatase E1, encoded by the mtnC gene, is a bifunctional enzyme involved in the methionine salvage pathway. It catalyzes two sequential reactions:
Enolase activity: Conversion of 2,3-diketo-5-methylthiopentyl-1-phosphate (DK-MTP-1-P) to 1,2-dihydroxy-3-keto-5-methylthiopentene (DHK-MTPene).
Phosphatase activity: Dephosphorylation of DHK-MTPene to 1,2-dihydroxy-3-keto-5-methylthiopentene (DHK-MTP) .
In Yersinia pseudotuberculosis serotype O:3, this enzyme is critical for metabolizing methylthioadenosine (MTA), a byproduct of polyamine biosynthesis, to regenerate methionine—a process essential for bacterial survival under sulfur-limiting conditions .
The mtnC gene is part of the mtnKABD operon in Y. pseudotuberculosis, which includes:
| Gene | Function |
|---|---|
| mtnK | 5-Methylthioribose kinase |
| mtnA | Dehydratase |
| mtnB | Enolase-phosphatase E1 (MtnC) |
| mtnD | Acireductone dioxygenase |
This operon enables the bacterium to utilize MTA as a sulfur source, enhancing its adaptability in host environments . Comparative genomic studies reveal that mtnC is conserved across Yersinia species but exhibits unique regulatory elements in Y. pseudotuberculosis serotype O:3, potentially linked to its pathogenicity .
Existing studies on Y. pseudotuberculosis focus on virulence factors (e.g., Yops, LcrV) and vaccine development , with limited emphasis on metabolic enzymes like MtnC. Key unanswered questions include:
Structural Characterization: No crystal structure of Y. pseudotuberculosis MtnC is available.
Role in Virulence: Whether MtnC contributes to pathogenicity or survival in host tissues remains unexplored.
Therapeutic Targeting: Potential as a drug target due to its role in methionine salvage .
| Feature | Y. pseudotuberculosis MtnC | E. coli MtnC |
|---|---|---|
| Molecular Weight | ~25 kDa (predicted) | ~23 kDa |
| Operon Structure | mtnKABD | mtnKABD |
| Subcellular Localization | Cytoplasmic | Cytoplasmic |
| Catalytic Efficiency | Not characterized | for DK-MTP-1-P |
KEGG: ypy:YPK_3320